Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-18T09:51:54.942Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (AUGUST 2007)

Published online by Cambridge University Press:  01 November 2007

R Sutherland
R Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journal Watch
Information
Breast Cancer Online , Volume 10 , Issue 11 , November 2007 , e22
Copyright
Copyright © Cambridge University Press 2007

References

1.Akli, S, Van Pelt, CS, Bui, TY, Multani, AS, Chang, S, Johnson, D, Tucker, S, Keyomarsi, K. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Res 2007; 67: 7212–7222.CrossRefGoogle ScholarPubMed
2.Almquist, M, Manjer, J, Bondeson, L, Bondeson, AG. Serum calcium, breast cancer risk: results from a prospective cohort study of 7,847 women. Cancer Causes Control 2007; 18: 595–602.CrossRefGoogle Scholar
3.Badve, S, Turbin, D, Thorat, MA, Morimiya, A, Nielsen, TO, Perou, CM, Dunn, S, Huntsman, DG, Nakshatri, H. FOXA1 expression in breast cancer – correlation with luminal subtype A and survival. Clin Cancer Res 2007; 13: 4415–4421.CrossRefGoogle ScholarPubMed
4.Bartsch, R, Wenzel, C, Altorjai, G, Pluschnig, U, Mader, RM, Gnant, M, Jakesz, R, Rudas, M, Zielinski, CC, Steger, GG. Her2 and progesterone receptor status are not predictive of response to fulvestrant treatment. Clin Cancer Res 2007; 13: 4435–4439.CrossRefGoogle Scholar
5.Chan, MM, Lu, X, Merchant, FM, Iglehart, JD, Miron, PL. Serial transplantation of NMU-induced rat mammary tumors: a model of human breast cancer progression. Int J Cancer 2007; 121: 474–485.CrossRefGoogle Scholar
6.Dent, R, Trudeau, M, Pritchard, KI, Hanna, WM, Kahn, HK, Sawka, CA, Lickley, LA, Rawlinson, E, Sun, P, Narod, SA. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13: 4429–4434.CrossRefGoogle ScholarPubMed
7.Drabsch, Y, Hugo, H, Zhang, R, Dowhan, DH, Miao, YR, Gewirtz, AM, Barry, SC, Ramsay, RG, Gonda, TJ. Mechanism of and requirement for estrogen- regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci USA 2007; 104: 13762–13767.CrossRefGoogle ScholarPubMed
8.Frankel, LB, Lykkesfeldt, AE, Hansen, JB, Stenvang, J. Protein kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells. Breast Cancer Res Treat 2007; 104: 165–179.CrossRefGoogle ScholarPubMed
9.Gadir, N, Jackson, DN, Lee, E, Foster, DA. Defective TGF-β signaling sensitizes human cancer cells to rapamycin. Oncogene 2007; 10.1038/sj.onc.1210721.Google ScholarPubMed
10.Gatenby, RA, Smallbone, K, Maini, PK, Rose, F, Averill, J, Nagle, RB, Worrall, L, Gillies, RJ. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 2007; 97: 646–653.CrossRefGoogle ScholarPubMed
11.Glass, AG, Lacey, JV, Carreon, D, Hoover, RN. Breast cancer incidence, 1980–2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007; 99: 1152–1161.CrossRefGoogle ScholarPubMed
12.Ince, TA, Richardson, AL, Bell, GW, Saitoh, M, Godar, S, Karnoub, AE, Iglehart, JD, Weinberg, RA. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 2007; 12: 160–170.CrossRefGoogle ScholarPubMed
13.Klein, A, Wessel, R, Graessmann, M, Juergens, M, Petersen, I, Schmutzler, R, Niederacher, D, Arnold, N, Meindl, A, Scherneck, S, Seitz, S, Graessmann, A. Comparison of gene expression data from human and mouse breast cancers: identification of a conserved breast tumor gene set. Int J Cancer 2007; 121: 683–688.CrossRefGoogle ScholarPubMed
14.Kotamraju, S, Willams, CL, Kalyanaraman, B. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. Cancer Res 2007; 67: 7386–7394.CrossRefGoogle ScholarPubMed
15.Kuo, PL, Chen, CY, Hsu, YL. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells. Cancer Res 2007; 67: 7406–7420.CrossRefGoogle ScholarPubMed
16.Kuorelahti, A, Rulli, S, Huhtaniemi, I, Poutanen, M. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGß transgenic female mice present with mammary gland tumors exhibiting characteristics of the wnt/ß-catenin pathway activation. Endocrinology 2007; 148: 3694–3703.CrossRefGoogle Scholar
17.Lahusen, T, Fereshteh, M, Oh, A, Wellstein, A, Riegel, AT. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Cancer Res 2007; 67: 7256–7265.CrossRefGoogle ScholarPubMed
18.Lu, D, Sivaprasad, U, Huang, J, Shankar, E, Morrow, S, Basu, A. Protein kinase C-epsilon protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation. Apoptosis 2007; 12: 1893–1900.CrossRefGoogle ScholarPubMed
19.Nangia-Makker, P, Tait, L, Shekhar, MPV, Palomino, E, Hogan, V, Piechocki, MP, Funasaka, T, Raz, A. Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum. Int J Cancer 2007; 121: 884–894.CrossRefGoogle ScholarPubMed
20.Ntukidem, NI, Nguyen, AT, Stearns, V, Rehman, M, Schott, A, Skaar, T, Jin, Y, Blanche, P, Li, L, Lemler, S, Hayden, J, Krauss, RM, Desta, Z, Flockhart, DA, Hayes, DF. Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin Pharmacol Ther 2007; 10.1038/sj.clpt.6100343.Google ScholarPubMed
21.Razanajaona, D, Joguet, S, Ay, AS, Treilleux, I, Goddard-Leon, S, Bartholin, L, Rimokh, R. Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth. Cancer Res 2007; 67: 7223–7229.CrossRefGoogle ScholarPubMed
22.Song, RXD, Zhang, ZG, Chen, YC, Bao, YD, Santen, RJ. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology 2007; 148: 4091–4101.CrossRefGoogle Scholar
23.Tamimi, RM, Byrne, C, Colditz, GA, Hankinson, SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007; 99: 1178–1187.CrossRefGoogle ScholarPubMed
24.Treszezamsky, AD, Kachnic, LA, Feng, ZH, Zhang, JR, Tokadjian, C, Powell, SN. BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II. Cancer Res 2007; 67: 7078–7081.CrossRefGoogle ScholarPubMed
25.Wendt, MK, Cooper, AN, Dwinell, MB. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 2007; 110.1038/sj.onc.1210751.Google ScholarPubMed
26.Williams, C, Edvardsson, K, Lewandowski, SA, Stroem, A, Gustafsson, JA. A genome-wide study of the repressive effects of estrogen receptor β on estrogen receptor α signaling in breast cancer cells. Oncogene 2007; 10.1038/sj.onc.1210712.Google ScholarPubMed
27.Zheng, AP, Kallio, A, Harkonen, P. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen. Endocrinology 2007; 148: 3931–3931.CrossRefGoogle ScholarPubMed